These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 179711)

  • 21. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
    Kugoh HM; Hashiba H; Shimizu M; Oshimura M
    Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.
    Dragović T; Deddish PA; Tan F; Weber G; Erdös EG
    Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Turnover of high-molecular-weight cell surface proteins during growth and expression of malignant transformation.
    Rieber M; Bacalao J; Alonso G
    Cancer Res; 1975 Aug; 35(8):2104-8. PubMed ID: 167946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
    Klinger HP; Shows TB
    J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A survey of growth in soft agar and cell surface properties as markers for transformation in adult rat liver epithelial-like cell cultures.
    San RH; Laspia MF; Soiefer AI; Maslansky CJ; Rice JM; Williams GM
    Cancer Res; 1979 Mar; 39(3):1026-34. PubMed ID: 427743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
    Shouval D; Reid LM; Chakraborty PR; Ruiz-Opazo N; Morecki R; Gerber MA; Thung SN; Shafritz DA
    Cancer Res; 1981 Apr; 41(4):1342-50. PubMed ID: 6260336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of myc gene amplification in human somatic cell hybrids.
    Iman DS; Shay JW
    Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogenesis in tissue culture 24: tumorigenicity and aggregate-forming capacity of mammalian cells in culture.
    Takaoka T; Katsuta H; Akatsuka T
    Jpn J Exp Med; 1975 Aug; 45(4):299-312. PubMed ID: 171466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of correlation between the decreased expression of cell surface LETS protein and tumorigenicity in human cell hybrids.
    Der CJ; Stanbridge EJ
    Cell; 1978 Dec; 15(4):1241-51. PubMed ID: 728999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumorigenicity and immunogenicity of somatic cell hybrids between L1210 mouse leukemia cell and L-fibroblast.
    Watanabe E; Kawashima K; Isobe K; Yamada K; Saga S; Takahashi T
    Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):121-9. PubMed ID: 6858561
    [No Abstract]   [Full Text] [Related]  

  • 32. Microfilament bundles, LETS protein and growth control in somatic cell hybrids.
    Marshall CJ; Humphryes KC; Pollack RE
    J Cell Sci; 1978 Oct; 33():191-204. PubMed ID: 363730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression in murine hybrids exhibiting different morphologies and tumorigenic properties.
    Bravo R; Fey SJ; Celis JE
    Carcinogenesis; 1981; 2(8):769-82. PubMed ID: 7285283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of differentiated functions in hepatoma cell hybrids: induction of mouse albumin production in rat hepatoma-mouse fibroblast hybrids.
    Peterson JA; Weiss MC
    Proc Natl Acad Sci U S A; 1972 Mar; 69(3):571-5. PubMed ID: 4335066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of single cell suspensions from hepatoma cells in culture.
    Tokiwa T; Doi I; Sato J
    Acta Med Okayama; 1975 Apr; 29(2):147-50. PubMed ID: 169672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extinction, retention and induction of serum protein secretion in hepatoma-fibroblast hybrids.
    Szpirer C; Szpirer J
    Differentiation; 1976 Jun; 5(2-3):97-9. PubMed ID: 61142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of differentiated functions in hepatoma cell hybrids: high frequency of induction of mouse albumin production in rat hepatoma-mouse lymphoblast hybrids.
    Malawista SE; Weiss MC
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):927-31. PubMed ID: 4362639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of in vivo malignancy with in vitro properties of human-mouse hybrid cells.
    Bordelon MR; Shows TB; Chen TR; Stubblefield E
    J Natl Cancer Inst; 1976 Mar; 56(3):499-508. PubMed ID: 1255782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The suppression of tumorigenicity in human X mouse cell hybrids. II. The relationship between tumorigenicity and parameters of transformation in vitro.
    Chopan M; Kopelovich L
    Exp Cell Biol; 1981; 49(3):132-40. PubMed ID: 7195844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of polypeptides whose presence correlates with retention or loss of an albumin extinguisher chromosome in rat hepatoma-mouse L cell fibroblast microcell hybrids.
    Laurent-Winter C; Fougère-Deschatrette C; Weiss MC
    Differentiation; 1994 Feb; 55(3):225-32. PubMed ID: 8187983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.